Design, development and evaluation of novel sustained release bi-layer tablets of lornoxicam based on the combination of hydrophilic matrix formers and basic pH modifiers

International Journal of Pharma and Bio Sciences

Volumn 3, Issue 4, 2012, Pages 392-402

  Karna, Nabin ^a  

^a Jodhpur National University   (India)

Author keywords

Basic pH modifier; Bi layer tablets; Hydrophilic matrix; Lornoxicam

Indexed keywords

ALCOHOL; BICARBONATE; DRUG CARRIER; LORNOXICAM; MAGNESIUM OXIDE; MAGNESIUM STEARATE; POLYMER; TALC;

ANALGESIC ACTIVITY; ANGLE OF REPOSE; ARTICLE; BULK DENSITY; CONTROLLED DRUG RELEASE; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; HYDROPHILICITY; IMMEDIATE DRUG RELEASE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MICROENVIRONMENT; PARTICLE SIZE; PH; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MANUFACTURE; TABLET MATRIX; TABLET THICKNESS; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84873843387     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Theeuwes F. Oros osmotic system development. Drug Dev Ind Pharm. 1983; 9:1331-1357.
2. Prasad BDS, Medhi B, Prakash A, Patyar S and Wadhwa S. Lornoxicam: A Newer NSAID. Ind J of Phys Med and Rehabil. 2009; 20(1): 27-31.
3. K. Kavitha And More Mangesh Rajendra, Design And Evaluation Of Transdermal Films Of Lornoxicam, IJPBS,2(2),54-62.
4. Gunsel W. C., Bunsel R. G., Pharmaceutical Dosage Forms: Tablets," ed. by Liebermann L. A., Lachman L., Schwartz J. B., 1989;Vol. 2, Marcel Dekker, Inc., N.Y; 274.
5. Ballard B. E., "Remington's Pharmaceutical Sciences," 16th ed., Easton, Mack Publishing Company1990;1600.
6. Mr. Ashish A Pahade, Dr. Mrs. V.M.Jadhav And Dr. Mr.V.J.Kadam, Formulation and Development Of a Bilayer Sustained Released Tablets of Isosorbide Mononitrate, IJPBS, 2010, 1(4), 305-314.
7. Phani kumar G K, Gangarao Battu, Love Raju N.S.Kotha, Prepration and Evaluation of Sustained release Matrix Tablet Of Lornoxicam, IJPDR, 2011, 2(12),89-98.
8. Rawlins EA. Bentley's Text Book of Pharmaceutics. London, England: Cassell and Collier MacMillan; 1977; 376
9. Shobha R. Text Book of Pharmaceutics and PharmacokineticsMumbai, India: Prism Book Pvt. Lmt. 2000; 176.
10. Raghuram RK, Srinivas M, Srinivas R. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation AAPS Pharm Sci Tech. 2003; 4: 61.
11. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Idustrial Pharmacy.Philadelphia, PA: Lea and Febiger; 1987;317-318.
12. Hariprasanna R.C, Qamar Jamal Ahmad, Upendra kulkarni, Design and Evaluation Twice Daily Lornoxicam Bi-Layer Matrix Tablets By Using Hydrophilic Polymer Sodium Alginate, AJBPR, 2011, 2(1),552-561.
13. Upendra kulkarni, Qamar Jamal Ahmad, Hariprasanna R.C, Formulation of Bilayer Lornoxicam Matrix Tablets: Influence of Some Hydrophilic Polymers on the Release Rate and In Vitro Evaluation, JPR, 2011, 7(4), 2233-2235.
14. S. K. Sheth, S. J. Patel and J. B. Shukla, Formulation and evaluation of taste masked oral disintegrating tablet of lornoxicam, IJPBS,2010, V1(2),1-9